Last reviewed · How we verify
NCT03735797
Cancer Stem Cells in Acute Leukemia
trial testing Bone marrow aspirate or peripheral blood sample collection in Acute Leukemia in 50 participants. Participants enrolled and being followed up; not accepting new ones.
1 March 2028
Quick facts
| Lead sponsor | Sanford Health |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 12 July 2017 |
| Primary completion | 1 March 2028 |
| Estimated completion | 1 March 2029 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Bone marrow aspirate or peripheral blood sample collection
Conditions studied
- Acute Leukemia — all drugs for Acute Leukemia →
Sponsor
Sanford Health — full company profile →
Who can join
Adults 1 Month to 30, any sex, with Acute Leukemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03735797
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Leukemia
Currently open trials in the same condition.
- NCT07270770 — BY002 IIT Study in R/R Acute Leukemia · Phase 1 · recruiting
- NCT07356154 — A Study of Revumenib and Mezigdomide in People With Leukemia · Phase 1, PHASE2 · recruiting
- NCT07362095 — Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) · Phase 1, PHASE2 · recruiting
- NCT07101497 — Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia · Phase 2 · recruiting
- NCT06984536 — Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT · Phase 2 · recruiting
Other Sanford Health trials
Trials by the same sponsor.
- NCT06883266 — Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD · NA · recruiting
- NCT06524349 — Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following AC · NA · active not recruiting
- NCT06008561 — Midwest Birth Outcomes and Indigenous American Pregnancy · recruiting
- NCT05798377 — Maternal Stress and Blood Sugar Metabolization · active not recruiting
- NCT05671913 — Scheduled Intranasal Ketamine · EARLY_PHASE1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03735797 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanford Health
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03735797.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing